Hsin-Hwa Tsai Selected Research

Hsin-Hwa Tsai Research Topics

8	Neoplasms (Cancer) 12/2023 - 11/2015
7	Rectal Neoplasms (Rectal Cancer) 03/2023 - 01/2021
3	Carcinogenesis 12/2023 - 01/2022
2	Cholangiocarcinoma 12/2023 - 10/2023
2	Nasopharyngeal Carcinoma 01/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2021
2	Liver Neoplasms (Liver Cancer) 01/2020 - 11/2015
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Atherosclerotic Plaque (Atheroma) 09/2017
1	Inflammation (Inflammations) 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2017

5	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2022
4	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2020 - 11/2015
2	Indicators and Reagents (Reagents)IBA 10/2023 - 07/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2017
2	Transcription Factors (Transcription Factor)IBA 09/2017 - 02/2017
1	Laminin (Merosin)IBA 12/2023
1	Heparin (Liquaemin)FDA LinkGeneric 12/2023
1	Cartilage Oligomeric Matrix ProteinIBA 10/2023
1	NucleotidesIBA 11/2022
1	CateninsIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	ForminsIBA 01/2022
1	Mucin-2IBA 07/2021
1	Cathepsin EIBA 07/2021
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021
1	aristolochic acid I (aristolochic acid)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021
1	APOBEC-1 DeaminaseIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020
1	LipidsIBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	Apolipoproteins E (ApoE)IBA 09/2017
1	Decitabine FDA Link 11/2015